These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15257691)

  • 1. Acute weakness in a previously asymptomatic elderly lady.
    Peters G; Villamil E; Wieshmann UC
    Eur J Neurol; 2004 Jul; 11(7):497. PubMed ID: 15257691
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary neuropathy unmasked by levofloxacin.
    Panas M; Karadima G; Kalfakis N; Vassilopoulos D
    Ann Pharmacother; 2011 Oct; 45(10):1312-3. PubMed ID: 21881033
    [No Abstract]   [Full Text] [Related]  

  • 3. Case records of the Massachusetts General Hospital. Case 18-2006. A 57-year-old woman with numbness and weakness of the feet and legs.
    Triggs WJ; Brown RH; Menkes DL
    N Engl J Med; 2006 Jun; 354(24):2584-92. PubMed ID: 16775239
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors associated with foot and ankle strength in healthy preschool-age children and age-matched cases of Charcot-Marie-Tooth disease type 1A.
    Rose KJ; Burns J; North KN
    J Child Neurol; 2010 Apr; 25(4):463-8. PubMed ID: 19671887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Reasoning: A patient with rapidly progressive sensory loss and imbalance.
    Lee E; Karam C; Chahin N
    Neurology; 2015 May; 84(19):e140-5. PubMed ID: 25964483
    [No Abstract]   [Full Text] [Related]  

  • 6. Strokelike Episodes in a Patient With Chronic Gait Abnormalities.
    Santoro JD; Chitnis T
    JAMA Neurol; 2019 May; 76(5):621-622. PubMed ID: 30801629
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aphasia and Weakness in a Child Think Beyond Stroke.
    Prior DE; Ghosh PS
    J Clin Neuromuscul Dis; 2021 Jun; 22(4):233-234. PubMed ID: 34019011
    [No Abstract]   [Full Text] [Related]  

  • 9. Charcot-Marie-Tooth disease type 1A associated with acute porphyric neuropathy.
    Jacob S; Damian MS; Rajabally YA
    Eur J Neurol; 2007 Nov; 14(11):e10-1. PubMed ID: 17956430
    [No Abstract]   [Full Text] [Related]  

  • 10. Charcot-Marie-Tooth disease associated with hip dysplasia: a case report.
    Cucuzzella TR; Guille JT; MacEwen GD
    Del Med J; 1996 Jun; 68(6):305-7. PubMed ID: 8698139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive evaluation of the variation in ankle function during gait in children and youth with Charcot-Marie-Tooth disease.
    Õunpuu S; Garibay E; Solomito M; Bell K; Pierz K; Thomson J; Acsadi G; DeLuca P
    Gait Posture; 2013 Sep; 38(4):900-6. PubMed ID: 23702343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot-Marie-Tooth disease mimicking ocular myasthenia gravis.
    Spector RH; Smith JL; Chavis PS
    Ann Ophthalmol; 1978 Aug; 10(8):1033-8. PubMed ID: 697278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charcot-Marie-Tooth disease masquerading as acute demyelinating encephalomyelitis-like illness.
    Kim GH; Kim KM; Suh SI; Ki CS; Eun BL
    Pediatrics; 2014 Jul; 134(1):e270-3. PubMed ID: 24958582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric orthopedic conditions in Charcot-Marie-Tooth disease: a literature review.
    Yagerman SE; Cross MB; Green DW; Scher DM
    Curr Opin Pediatr; 2012 Feb; 24(1):50-6. PubMed ID: 22189393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of a new genetic entity in the form of an autosomal dominant axonal Charcot-Marie-Tooth disease associated with periodic paralyses and pyramidal syndrome].
    Chokri B; Salem M; Faycel H
    Tunis Med; 2005 Sep; 83(9):547-55. PubMed ID: 16383201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The central nervous system phenotype of X-linked Charcot-Marie-Tooth disease: a transient disorder of children and young adults.
    Al-Mateen M; Craig AK; Chance PF
    J Child Neurol; 2014 Mar; 29(3):342-8. PubMed ID: 23400245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charcot-Marie-Tooth disease.
    Buteică E; Roşulescu E; Stănoiu B; Burada F; Stănoiu C; Zăvăleanu M
    Rom J Morphol Embryol; 2008; 49(1):115-9. PubMed ID: 18273515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypothesis of overwork weakness in Charcot-Marie-Tooth: a critical evaluation.
    van Pomeren M; Selles RW; van Ginneken BT; Schreuders TA; Janssen WG; Stam HJ
    J Rehabil Med; 2009 Jan; 41(1):32-4. PubMed ID: 19197566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system signs in X-linked Charcot-Marie-Tooth disease after hyperventilation.
    Srinivasan J; Leventer RJ; Kornberg AJ; Dahl HH; Ryan MM
    Pediatr Neurol; 2008 Apr; 38(4):293-5. PubMed ID: 18358413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine neurotoxicity in the presence of hereditary neuropathy.
    Trobaugh-Lotrario AD; Smith AA; Odom LF
    Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.